chartexchange

ANTX
AN2 Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseNov 13, 2026 3:59:59 PM EST
4.57USD+2.928%(+0.13)205,686
After-hoursNov 13, 2026 4:00:30 PM EST
4.55USD-0.438%(-0.02)
Loading…
Loading…
173.40M
Healthcare
Biotechnology
HQ
Menlo Park, CA, USA
56,000
Previous Close
$4.44
Beta
0.55
52-Week High
$7.19 2026-08-12
52-Week Low
$1.00 2026-02-19
SMA 50
$4.64
SMA 200
$4.21
Avg. Vol 10D
242,214
Avg. Vol 30D
298,123
Avg. Vol 90D
250,646
Relative Vol
0.69
22.40M
1.8500%
3,427
ANTX Profile

an2 therapeutics, inc. is a california-based global health biopharmaceutical company focused on bringing the power of modern biomedical and drug development expertise to provide transformational medicines for patients suffering from infectious diseases. an2 is a mission-driven company, with a vision for humanity to be free from the threat of infectious diseases by addressing the urgent need for new treatments that can save lives across the globe. founded by a small team of biopharmaceutical industry leaders with a passion for global health and experience in infectious disease drug r&d, we strive to bring patients treatments that will restore their health and enable them to live productive lives.

ANTX Performance
PeriodPriceDateChangeBeta
1W4.002026-11-06+14.25%-1.281
1M3.602026-10-13+26.94%1.682
3M5.982026-08-13-23.58%0.947
6M4.312026-05-13+6.03%0.951
1Y1.132025-11-13+304.43%0.547
2Y1.012024-11-13+352.48%—
5Y15.402022-03-25-70.33%0.800
ANTX Stock Summary

AN2 Therapeutics, Inc. Common Stock (NASDAQ:ANTX) stock price today is $4.57, and today's volume is 205,686. ANTX is up 2.928% today. The 30 day average volume is 298,123. ANTX market cap is $173.40M with 37.94M shares outstanding.